AZIYO BIOLOGICS INC-CLASS A (AZYO)
US05479K1060 - Common Stock
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today...
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable...
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up...
Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic...
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...
Aziyo Biologics recalling bone repair products (NASDAQ:AZYO)
Aziyo Biologics (AZYO) is recalling its viable bone matrix products after two patients developed an infection. Read more here.
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
SILVER SPRING, Md., July 13, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products...
3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential
The smallest stocks have been trailing their larger counterparts. Here are three top micro-cap stocks to ride the asset class' resurgence.
Aziyo posts data for healing product in cardiac implantation
Aziyo Biologics (AZYO) added 6% pre-market Friday on interim study data supporting the potential of its healing product CanGaroo Biologics Envelope. Read more here.
Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope
Study Presented at Heart Rhythm Society Supports Wound-Healing Benefits in Patients Receiving Cardiac Implantable Electronic Devices SILVER SPRING, Md.,...
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
- All Four Business Segments Achieved Growth Led by Strong SimpliDerm and CanGaroo Sales - SILVER SPRING, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Aziyo...
Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
SILVER SPRING, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic...
Why Shares of LeMaitre Vascular Are Up Wednesday
LeMaitre announced first-quarter earnings and guidance numbers.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular Portfolio
SILVER SPRING, Md., April 20, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Aziyo Biologics Reports Record Full Year 2022 Revenues
SILVER SPRING, Md., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes...
Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction
SILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and...
AZYO stock falls on setback for marketing request for antibacterial product (NASDAQ:AZYO)
Aziyo Biologics (AZYO) lost ~54% premarket Monday after the FDA noted deficiencies in its marketing application for CanGaroo RM Antibacterial Envelope. Read the full story here.